0001193125-20-214579.txt : 20200810 0001193125-20-214579.hdr.sgml : 20200810 20200810135752 ACCESSION NUMBER: 0001193125-20-214579 CONFORMED SUBMISSION TYPE: 497 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20200810 DATE AS OF CHANGE: 20200810 EFFECTIVENESS DATE: 20200810 FILER: COMPANY DATA: COMPANY CONFORMED NAME: COLUMBIA ACORN TRUST CENTRAL INDEX KEY: 0000002110 IRS NUMBER: 362692100 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 497 SEC ACT: 1933 Act SEC FILE NUMBER: 002-34223 FILM NUMBER: 201088711 BUSINESS ADDRESS: STREET 1: 71 S. WACKER DRIVE, SUITE 2500 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 3126349200 MAIL ADDRESS: STREET 1: 71 S. WACKER DRIVE, SUITE 2500 CITY: CHICAGO STATE: IL ZIP: 60606 FORMER COMPANY: FORMER CONFORMED NAME: LIBERTY ACORN TRUST DATE OF NAME CHANGE: 20010424 FORMER COMPANY: FORMER CONFORMED NAME: ACORN INVESTMENT TRUST DATE OF NAME CHANGE: 19940204 FORMER COMPANY: FORMER CONFORMED NAME: ACORN FUND INC DATE OF NAME CHANGE: 19920703 0000002110 S000009188 Columbia Acorn International Select C000024970 Columbia Acorn International Select Class A LAFAX C000024972 Columbia Acorn International Select Class C LFFCX C000024973 Columbia Acorn International Select Institutional Class ACFFX C000122746 Columbia Acorn International Select Institutional 2 Class CRIRX C000122747 Columbia Acorn International Select Institutional 3 Class CSIRX C000122748 Columbia Acorn International Select Advisor Class CILRX 497 1 d33205d497.htm COLUMBIA ACORN TRUST Columbia Acorn Trust
Supplement dated August 10, 2020
to the Prospectus, as supplemented, of the following Fund (the Fund):
Fund Prospectus Dated
Columbia Acorn Trust  
 Columbia Acorn International SelectSM 5/1/2020
The reorganization of Columbia Select International Equity Fund with and into Columbia Acorn International Select (the Fund) closed on August 7, 2020. Therefore, effective immediately the Investment Manager's contractual agreement to waive fees and reimburse certain expenses of the Fund is extended through April 30, 2022 as described in this Supplement.
1. The "Summary of the Fund - Fees and Expenses of the Fund" section of the Prospectus is revised to replace the "Shareholder Fees" and "Annual Fund Operating Expenses" tables, and the information under the caption "Example" with the following information:
    
Shareholder Fees (fees paid directly from your investment)
  Class A Class C Classes Adv, Inst,
Inst2, and Inst3
Maximum sales charge (load) imposed on purchases (as a % of offering price) 5.75% None None
Maximum deferred sales charge (load) imposed on redemptions (as a % of the lower of the original purchase price or current net asset value) 1.00% (a) 1.00% (b) None
    
Annual Fund Operating Expenses (expenses that you pay each year as a percentage of the value of your investment)
  Class A Class Adv Class C Class Inst Class Inst2 Class Inst3
Management fees 0.89% 0.89% 0.89% 0.89% 0.89% 0.89%
Distribution and/or service (12b-1) fees 0.25% 0.00% 1.00% 0.00% 0.00% 0.00%
Other expenses(c) 0.39% 0.39% 0.39% 0.39% 0.32% 0.27%
Total annual Fund operating expenses 1.53% 1.28% 2.28% 1.28% 1.21% 1.16%
Less: Fee waivers and/or expense reimbursements(d) (0.25%) (0.25%) (0.25%) (0.25%) (0.31%) (0.31%)
Total annual Fund operating expenses after fee waivers and/or expense reimbursements 1.28% 1.03% 2.03% 1.03% 0.90% 0.85%
(a) This charge is imposed on certain investments of between $1 million and $50 million redeemed within 18 months after purchase, as follows: 1.00% if redeemed within 12 months after purchase, and 0.50% if redeemed more than 12, but less than 18, months after purchase, with certain limited exceptions.
(b) This charge applies to redemptions within 12 months after purchase, with certain limited exceptions.
(c) Other expenses have been restated to reflect current fees paid by the Fund.
(d) Columbia Wanger Asset Management, LLC (the Investment Manager) has contractually agreed to waive fees and reimburse certain expenses of the Fund, through April 30, 2022, so that ordinary operating expenses (excluding any reorganization costs, transaction costs and certain other investment-related expenses, interest and fees on borrowings and expenses associated with the Fund’s investment in other investment companies, if any) do not exceed the annual rates of 1.28% for Class A shares, 1.03% for Class Adv shares, 2.03% for Class C shares, 1.03% for Class Inst shares, 0.90% for Class Inst2 shares and 0.85% for Class Inst3 shares. This arrangement may only be amended or terminated with approval from the Fund’s Board of Trustees and the Investment Manager.
Example
The following example is intended to help you compare the cost of investing in the Fund with the cost of investing in other mutual funds. The example illustrates the hypothetical expenses that you would incur over the time periods indicated, and assumes that:
you invest $10,000 in the applicable class of Fund shares for the periods indicated,
your investment has a 5% return each year, and
the Fund’s total annual operating expenses remain the same as shown in the Annual Fund Operating Expenses table above.
SUP112_12_007_(08/20)

 

Since the waivers and/or reimbursements shown in the Annual Fund Operating Expenses table above expire as indicated in the preceding table, they are only reflected in the 1 year example and the first year of the other examples. Although your actual costs may be higher or lower, based on the assumptions listed above, your costs would be:
    
  1 year 3 years 5 years 10 years
Class A (whether or not shares are redeemed) $698 $1,007 $1,339 $2,274
Class Adv (whether or not shares are redeemed) $105 $ 381 $ 678 $1,523
Class C (assuming redemption of all shares at the end of the period) $306 $ 688 $1,197 $2,596
Class C (assuming no redemption of shares) $206 $ 688 $1,197 $2,596
Class Inst (whether or not shares are redeemed) $105 $ 381 $ 678 $1,523
Class Inst2 (whether or not shares are redeemed) $ 92 $ 353 $ 635 $1,438
Class Inst3 (whether or not shares are redeemed) $ 87 $ 338 $ 608 $1,381
The rest of the section remains the same.
2. The information under the caption "Fee Waiver/Expense Reimbursement Arrangements" in the "More Information About the Fund - Additional Investment Strategies and Policies" section of the Prospectus is hereby removed and replaced with the following information:
Effective July 1, 2016, the Investment Manager has contractually agreed to permanently reduce the investment advisory fee payable to it by the Fund by 0.05% at all net asset levels.
The Investment Manager has contractually agreed to waive fees and reimburse certain expenses of the Fund through April 30, 2022, so that ordinary operating expenses (excluding any reorganization costs, transaction costs and certain other investment-related expenses, interest and fees on borrowings, and expenses associated with the Fund’s investment in other investment companies, if any) do not exceed the annual rates of:
    
Columbia Acorn International Select
Class A 1.28%
Class Adv 1.03%
Class C 2.03%
Class Inst 1.03%
Class Inst2 0.90%
Class Inst3 0.85%
This arrangement may only be amended or terminated with approval from the Fund’s Board of Trustees and the Investment Manager.
In addition to the contractual agreement, the Investment Manager and certain of its affiliates have voluntarily agreed to waive fees and/or reimburse Fund expenses (excluding any reorganization costs, transaction costs and certain other investment-related expenses, interest and fees on borrowings, and expenses associated with the Fund's investment in other investment companies, if any) so that Fund level expenses (expenses directly attributable to the Fund and not to a specific share class) are waived proportionately across all share classes. This arrangement may be revised or discontinued at any time.
Effect of Fee Waivers and/or Expense Reimbursements on Past Performance. The Fund’s returns shown in the Performance Information section of this prospectus reflect the effect of any fee waivers and/or reimbursements of Fund expenses by the Investment Manager and/or any of its affiliates and any predecessor firms that were in place during the performance period shown. Without such fee waivers/expense reimbursements, the Fund’s returns might have been lower.
The rest of the section remains the same.
Shareholders should retain this Supplement for future reference.
2
SUP112_12_007_(08/20)